In August 2024, Madhabi Puri Buch, then-chairperson of India’s market regulator Securities and Exchange Board of India (Sebi) ...

SEBI’s response clarifies that no additional compliance burden has been imposed through the 2024 amendments, maintaining existing requirements for listed companies, intermediaries, and fiduciaries.

Drug maker Allchem Lifescience has filed preliminary papers with markets regulator Sebi seeking its approval to raise funds ...

SEBI clarified that Angel Funds can invest only in startups meeting the Department for Promotion of Industry and Internal Trade (DPIIT) criteria. If a portfolio company loses its startup status, Angel ...

Markets regulator Sebi has widened the ambit of the scope of Unpublished Price Sensitive Information (UPSI) by including any ...

The Securities and Exchange Board of India (SEBI) is considering tweaking its employee appraisal system by severing the link ...

One of the key factors was its decision to change the expiry for the Sensex F&O contract from Thursdays to Fridays. Following ...

The so-called 'product suitability framework' has not come up for discussions in recent meetings at Sebi, and there has been ...

The legal framework surrounding fair comment, influence-peddling, defamation and fraud in social media interactions is still ...

LG Electronics India, a subsidiary of LG, has received approval from Sebi for a Rs 15,000 crore initial public offering. This ...

SEBI may require retail F&O traders to pass a suitability test, ensuring they understand risks. Discover more on this ...